NCT06386146
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06386146
Title JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Jacobio Pharmaceuticals Co., Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Research Site RECRUITING Denver Colorado 80218 United States Details
Research site RECRUITING Lake Mary Florida 32771 United States Details
Research site RECRUITING St Louis Missouri 63110 United States Details
Research site TERMINATED Canton Ohio 44718 United States Details
Research site RECRUITING Cleveland Ohio 44195 United States Details
Research Site RECRUITING Nashville Tennessee 37203 United States Details
Research site RECRUITING Houston Texas 77030 United States Details
Research Site RECRUITING Beijing Beijing Municipality 100000 China Details
Research Site RECRUITING Beijing Beijing Municipality 100021 China Details
Research Site RECRUITING Beijing Beijing Municipality 100142 China Details
Research Site NOT_YET_RECRUITING Guangzhou Guangdong 510000 China Details
Research Site NOT_YET_RECRUITING Jinan Shandong 250117 China Details
Research Site RECRUITING Shanghai Shanghai Municipality 200032 China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field